What exactly do we mean by the term "killer acquisitions," and how are those deals analyzed any differently by antitrust enforcers? In this episode, host Anant Raut talks to economist Dr. Ethel Fonseca of RBB Economics and antitrust attorney Danny Mader of Hogan Lovells LLP about how potential "killer acquisitions" get reviewed by competition agencies, using real-world examples such as Sabre/Farelogix, Visa/Plaid, and Facebook/Instagram. They explore the complexities of merger analysis, the nuances of potential competition, and how the same deal can have different outcomes in the US and the UK.

With special guests:
Dr. Ethel Fonseca, Partner, RBB Economics and Daniel Mader, Senior Associate, Hogan Lovells LLP

Hosted by:
Anant Raut

How do tariffs redefine product markets? In this episode, economist Dr. Craig Malam and antitrust expert Carla Hine join host Anant Raut to discuss the effect of the Trump Administration's tariff-centric trade policy on how we determine the edges of a product market and what constitutes a substitutable product. Panelists then talk about what economists and defense counsel should take into account when the size and duration of a tariff can change with a social media post.

With special guests:
Dr. Craig Malam, Partner, Edgeworth Economics and Carla Hine, Weil Gotshal & Manges LLP

Hosted by:
Anant Raut

Enforcers and policymakers have raised concerns that dominant firms like Google, Microsoft, NVIDIA, and Meta are extending their market power into AI by taking stakes in some of the most promising startups. In this episode, economist Dr. Elizabeth Wang and antitrust litigator Daniel Culley join me to discuss how economists measure the risk that a dominant firm could acquire its way into dominance in another market, as well as how to spot flaws in those projections.

With special guests:
Daniel Culley, Partner, Cleary Gottlieb Steen & Hamilton LLP and Dr. Elizabeth Wang, Partner and Head of the China Practice, Econic Partners, LLC

Hosted by:
Anant Raut